arrow_back Back to App

Safe Communication for Emergency Use Vaccines

New rules make it easier to share information about vaccines authorized for emergency use, provided the information is truthful and backed by scientific evidence. This aims to ensure healthcare providers have access to comprehensive vaccine data, potentially influencing treatment and prevention decisions.
Key points
Allows freer exchange of information about emergency-use vaccines between manufacturers and healthcare providers.
Information must be truthful, based on reliable scientific evidence, and include required disclaimers.
Aims to help better understand vaccine effects, even if used in ways not initially described on labels.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_3705
Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
Process start date: 2021-06-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To amend the Federal Food, Drug, and Cosmetic Act to include a safe harbor for communication of information with respect to a vaccine authorized for emergency use under such Act that is provided or distributed to a health care provider, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_3705.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-06-04.

What are the main provisions?

Key points include:

  • Allows freer exchange of information about emergency-use vaccines between manufacturers and healthcare providers.
  • Information must be truthful, based on reliable scientific evidence, and include required disclaimers.
  • Aims to help better understand vaccine effects, even if used in ways not initially described on labels.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Griffith, H. Morgan [R-VA-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health